Recruiting studies: Oligometastatic Lung Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup
Phase N/A · 2 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT07441941 Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease
Phase 3 · 6 location(s) · Vastra Gotaland Region · NCT06141070 First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Ca
Phase 3 · 3 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06840782 Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Opt
Phase N/A · 1 location(s) · Klinikum Esslingen · NCT04926584 Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
Phase 2 · 1 location(s) · Tata Memorial Hospital · NCT05277844 A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC
Phase 2 · 1 location(s) · Zhejiang University · NCT05837052 Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Phase 3 · 1 location(s) · Roswell Park Cancer Institute · NCT06563388 PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients
NA · 1 location(s) · National Cancer Institute, Naples · NCT04854213 Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment
NA · 2 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT04852588 The Impact of Radiotherapy on Oligometastatic Cancer
Phase N/A · 21 location(s) · Institut Investigacio Sanitaria Pere Virgili · NCT05933876 'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)
Phase 2 · 2 location(s) · Cancer Trials Ireland · NCT04375904 Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
Phase 1/Phase 2 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT05501665 Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC
Phase 3 · 1 location(s) · Tata Memorial Hospital · NCT05278052 Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for C
Phase 2 · 12 location(s) · Memorial Sloan Kettering Cancer Center · NCT03808337 A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligo
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06177925 Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC
Phase 2 · 5 location(s) · Universität des Saarlandes · NCT06223711 Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07325864

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.